Clinical Outcomes of Patients Implanted With the RxSight Light Adjustable Lens (LAL)

July 3, 2024 updated by: Vance Thompson Vision

The objective of this investigator initiated study (IIT-002) is to collect data on commercial patients implanted with the RxSight Light Adjustable Lens (LAL).

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Other: Data collection

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

United States
- South Dakota
  - Sioux Falls, South Dakota, United States, 57108
    - Vance Thompson Vision

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

Adult
Older Adult

Accepts Healthy Volunteers

Sampling Method

Non-Probability Sample

Study Population

Up to 50 commercial patients who have been implanted with the LAL and who have completed Light Delivery Device (LDD) light treatments.

Description

Inclusion Criteria:

Sign a written Informed Consent Document
Implanted commercially with the LAL and completed LDD light treatments

Exclusion Criteria:

Previous corneal or intraocular surgery other than removal of cataract and implantation of the LAL

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Manifest refraction Time Frame: Pre operatively and immediately post operatively	A qualified ophthalmologist, optometrist, or a trained ophthalmic technician should obtain the refraction, in 0.25D steps, in a calibrated refraction lane. If the subject has a current pair of glasses for distance vision, they can be measured with a lensometer, and these measurements are used as the beginning approximate refraction	Pre operatively and immediately post operatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Vance Thompson Vision

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 13, 2021

Primary Completion (Estimated)

January 1, 2022

Study Completion (Estimated)

January 1, 2022

Study Registration Dates

First Submitted

May 16, 2024

First Submitted That Met QC Criteria

July 3, 2024

First Posted (Actual)

July 5, 2024

Study Record Updates

Last Update Posted (Actual)